Trial intelligence / Profile preview

Narcotrend-guided propofol sedation for pediatric gastrointestinal endoscopy

2013-002122-23Phase 4Active

Sponsor
Erasmus MC
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol (2 arms), sponsored by Erasmus MC. Primary endpoint: Speed of recovery from procedural sedation. Started Jul 2013; status: active.

02

Drugs

propofol

Beyond the preview

Go deeper on 2013-002122-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002122-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call